Join Seven O’Day, M.D., Professor of Medical Oncology, Director of Immuno-Oncology, and Director of Clinical Research at the John Wayne Cancer Institute as he presents, High Risk Stage Melanoma: Update of adjuvant and Neoadjuvant Checkpoint Immunotherapy, on August 25 at the CSCO 4th Beijing International Melanoma Congress.

Saturday, August 25, 2018 at 2:30 PM – 2:50 PM
Chinese Society of Clinical Oncology
4th Beijing International Melanoma Congress